Results 31 to 40 of about 4,240,909 (230)

CA19-9 for detecting recurrence of pancreatic cancer [PDF]

Scientific Reports, 2020
AbstractCA19-9 values are regularly measured in patients with pancreatic cancer. Certainly, its potential as a biomarker has been compromised by false negative results in CA19-9 negative patients and false positive results in benign pancreatico-biliary diseases. For detection of PDAC recurrence, however, CA19-9 might play an important role.
Azadeh Azizian, Felix Rühlmann, Tanja Krause, Markus Bernhardt, Peter Jo, Alexander König, Mathias Kleiß, Andreas Leha, Michael Ghadimi, Jochen Gaedcke   +9 more
openaire   +3 more sources

Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9

Frontiers in Oncology, 2020
Recently we showed that delta radiomics features (DRF) from daily CT-guided chemoradiation therapy (CRT) is associated with early prediction of treatment response for pancreatic cancer.
Haidy Nasief, William Hall, Cheng Zheng, Susan Tsai, Liang Wang, Beth Erickson, X. Allen Li   +6 more
doaj   +1 more source

Prognostic Role of Carbohydrate Antigen 19 to 9 in Predicting Survival of Patients With Pancreatic Cancer: A Meta-Analysis

Technology in Cancer Research & Treatment, 2021
This study evaluates the prognostic role of carbohydrate antigen 19 to 9 (CA19-9) in predicting survival of pancreatic cancer patients. Literature search was conducted in electronic databases (Google Scholar, Ovid, PubMed, and Science Direct) and study ...
Yong-Ming Kang MD, Hao Wang MD, Ran Li MD, Gu Pan MD   +3 more
doaj   +1 more source

Detection of Carbohydrate Antigen CA19-9 Levels in Sera and Tissues' Homogenate of Breast and Thyroid Benign Cases

Iraqi Journal of Pharmaceutical Sciences, 2017
The aims of the present study are to evaluate the levels of CA19-9 in sera and tissues' homogenate of breast and thyroid benign patients in order to assess its use as an early diagnostic parameter in differentiation between malignant and benign cases ...
Gheid H. Alubaidi, Zeyan A. Ali, Abdulrahman R. Mahmood   +2 more
doaj   +3 more sources

Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution

BMC Surgery, 2022
Background Postoperative pancreatic fistula (POPF) is a critical complication of pancreatectomy in patients with pancreatic ductal adenocarcinoma (PDAC). Recent papers reported that serum carbohydrate antigen (CA)19-9 levels predicted long-term prognosis.
Hiroki Sugita, Hirohisa Okabe, Daisuke Ogawa, Hiroki Hirao, Daisuke Kuroda, Katsunobu Taki, Shinjiro Tomiyasu, Masahiko Hirota   +7 more
doaj   +1 more source

Increased carbohydrate antigen 19‐9 expression in a thymic neuroendocrine tumor

Thoracic Cancer, 2021
Here, we report a case of carbohydrate antigen (CA) 19‐9‐producing mediastinal neuroendocrine tumor (NET) (atypical carcinoid). A 54‐year‐old woman with no specific relevant medical history was referred to our hospital because of increased CA19‐9 (95.3 U/
Yuki Shimizu, Shintaro Kanda, Toshirou Fukushima, Takashi Kobayashi, Ryoichi Kondo, Tomonobu Koizumi   +5 more
doaj   +1 more source

STUDY OF DES-GAMMA-CARBOXYPROTHROMBIN (DCP) LEVELS IN CHRONIC HEPATITIS C WITH OR WITHOUT HEPATOCELLULAR CARCINOMA (HCC) IN EGYPTIAN PATIENTS [PDF]

Al-Azhar Journal of Pharmaceutical Sciences, 2015
Hepatocellular carcinoma (HCC) is usually asymptomatic in the early stage and does not show elevated alpha-feto protein (AFP). Des-Gamma-CarboxyProthrombin (DCP) and Carbohydrate antigen 19-9 (CA19-9) may increase in sera of HCC patients.
Omnia Kamel
doaj   +1 more source

Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study

BMC Cancer, 2022
Objective Whether preoperative serum carbohydrate antigen 19–9 (CA19-9) is an independent prognostic factor and there are interactions of serum CA19-9 with carcinoembryonic antigen (CEA) on the risk of recurrence in colorectal cancer (CRC) patients are ...
Zhenhui Li, Haibin Zhu, Xiaolin Pang, Yun Mao, Xiaoping Yi, Chunxia Li, Ming Lei, Xianshuo Cheng, Lei Liang, Jiamei Wu, Yingying Ding, Jun Yang, Yingshi Sun, Tao Zhang, Dingyun You, Zaiyi Liu   +15 more
doaj   +1 more source

Association between cancer antigen 19‐9 and diabetes risk: A prospective and Mendelian randomization study

Journal of Diabetes Investigation, 2020
Aims/Introduction Elevated serum cancer antigen 19‐9 (CA19‐9) levels have been found in diabetes patients in most observational studies; however, whether there is a causal association between CA19‐9 and diabetes mellitus is unclear. Materials and Methods
Zhaoyang Li, Jing Wang, Xu Han, Fei Wang, Hua Hu, Jing Yuan, Ping Yao, Sheng Wei, Huan Guo, Dan Zheng, Yuhan Tang, Handong Yang, Meian He   +12 more
doaj   +1 more source

Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer

Discover Oncology, 2023
Background Carbohydrate antigen 19–9 (CA19-9) is the most widely used biomarker for pancreatic cancer. Since CA19-9 closely correlates with patient outcome and tumor stage in pancreatic cancer, the deciphering of CA19-9 biosynthesis provides a potential ...
Chen Liu, Shengming Deng, Zhiwen Xiao, Renquan Lu, He Cheng, Jingjing Feng, Xuxia Shen, Quanxing Ni, Weiding Wu, Xianjun Yu, Guopei Luo   +10 more
doaj   +1 more source